[CHM] QoQ Quarter Result on 30-Jun-2022 [#Q4]

Stock
[CHM] Chimeric Therapeutics Limited
Announcement Date
29-Jun-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q4]
Profit Trend
QoQ- -99.97%
YoY- 46.06%
Quarter Report
CHM's Result
CHM's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
Revenue 706 1,505 1,505 1,309 1,309 0 0 -
PBT -7,090 -14,737 -5,822 -6,046 -3,023 -9,689 -4,844 28.94%
Tax 6 -2,990 52 164 82 4,574 0 -
NP -7,085 -11,748 -5,874 -6,209 -3,105 -9,689 -4,844 28.88%
Tax Rate - - - - - - - -
Total Cost 7,790 13,252 7,379 7,518 4,413 9,689 4,844 37.30%
Ratio Analysis
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
NP Margin -1,003.76 -780.61 -390.30 -474.53 -237.26 0.00 0.00 -
Per Share
31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 CAGR
EPS -0.02 -0.03 -0.01 -0.02 -0.01 -0.03 -0.01 58.80%
EPS Diluted -0.02 -0.03 -0.01 -0.02 -0.01 -0.03 -0.01 58.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.